Exogenous Cushing syndrome from an unexpected source of systemic steroids.

MedStar author(s):
Citation: Pediatric Dermatology. 35(3):e196-e197, 2018 May.PMID: 29574945Institution: MedStar Washington Hospital Center Marie CarverDepartment: DermatologyForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Cushing Syndrome/ci [Chemically Induced] | *Glucocorticoids/ae [Adverse Effects] | *Prednisolone/ae [Adverse Effects] | *Prednisone/ae [Adverse Effects] | Child | Cushing Syndrome/di [Diagnosis] | Dermatitis, Atopic/dt [Drug Therapy] | Humans | Male | Prednisolone/ad [Administration & Dosage] | Prednisone/ad [Administration & Dosage]Year: 2018ISSN:
  • 0736-8046
Name of journal: Pediatric dermatologyAbstract: A 12-year-old Hispanic boy with chronic atopic dermatitis and cushingoid features presented to our institution. He was being treated with an unknown quantity of oral prednisolone 15 mg/5 mL, equivalent to 70 mg/m<sup>2</sup> /d of oral prednisone, purchased over the counter in El Salvador. Systemic corticosteroids are not recommended for chronic therapy of atopic dermatitis because of their significant adverse effects. Foreign-sourced pharmaceuticals account for almost half of the drugs consumed in the United States, which means that, to protect our patients, medical providers must inquire about and report unsafe medications deemed legal outside the United States to the Food and Drug Administration.Copyright (c) 2018 Wiley Periodicals, Inc.All authors: DeKlotz CMC, O'Brien KF, Silverman RAFiscal year: FY2018Digital Object Identifier: Date added to catalog: 2018-04-20
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 29574945 Available 29574945

A 12-year-old Hispanic boy with chronic atopic dermatitis and cushingoid features presented to our institution. He was being treated with an unknown quantity of oral prednisolone 15 mg/5 mL, equivalent to 70 mg/m<sup>2</sup> /d of oral prednisone, purchased over the counter in El Salvador. Systemic corticosteroids are not recommended for chronic therapy of atopic dermatitis because of their significant adverse effects. Foreign-sourced pharmaceuticals account for almost half of the drugs consumed in the United States, which means that, to protect our patients, medical providers must inquire about and report unsafe medications deemed legal outside the United States to the Food and Drug Administration.

Copyright (c) 2018 Wiley Periodicals, Inc.

English

Powered by Koha